Critical SP500 Stock Alerts: Citigroup, EMC, AbbVie, Mondelez International, U.S. Bancorp, and KeyCorp



Insiderslab.com has issued insider trading reports and equity research for the following companies: Citigroup (NYSE:C), EMC (NYSE:EMC), AbbVie (NYSE:ABBV), Mondelez International (NASDAQ:MDLZ), U.S. Bancorp (NYSE:USB), and KeyCorp (NYSE:KEY).
 
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
 
Report Highlights:
 
Citigroup Inc. (NYSE:C): Earlier this month, Citigroup Inc. (NYSE:C) announced the appointment of Jamie Forese and Manuel Medina-Mora as Co-Presidents. Moreover, Jim Cowles has been named as Chief Executive Officer of Citi’s Europe, Middle East and Africa region. What’s more, Hamid Biglari, the Head of emerging markets, is leaving the bank, Chief Executive Michael Corbat announced on Monday. Investors may want to find out how Citigroup insiders are thinking about the future of the company. Check this insider trade report for C here.
 
Read Full Report: http://www.insiderslab.com/PR3/011713A/C/Citigroup.pdf
 
EMC Corporation (NYSE:EMC): In the last three months, EMC Corporation (NYSE:EMC) insiders have totally sold US$20.44 million worth of stock, which ranged in price from US$24.69 to US$25.15 each, according to insider trading report. On January 16, the company announced significant hardware and software updates to its market-leading EMC VMAX Family. The EMC VMAX 10K, the entry product to the VMAX Family, is the current’s highest-performing of its class in the industry-and is up to twice more powerful than its predecessor. See insider trade report for EMC here.
 
Read Full Report: http://www.insiderslab.com/PR3/011713A/EMC/EMC.pdf
 
AbbVie Inc. (NYSE:ABBV): AbbVie Inc. (NYSE:ABBV) is a research-based biopharmaceutical company formed in 2013 following separation from Abbott. Earlier this month, AbbVie’s Board of Directors declared its first quarterly cash dividend of US$0.40 per share, payable on February 15, 2013 to stockholders of record on January 15, 2013. The company will post its financial results for fourth quarter and full year 2012 on Wednesday, January 23. Check this insider trade report for ABBV here.
 
Read Full Report: http://www.insiderslab.com/PR3/011713A/ABBV/AbbVie.pdf
 
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
 
Mondelez International Inc. (NASDAQ:MDLZ):
Read Full Report: http://www.insiderslab.com/PR3/011713A/MDLZ/MondelezInternational.pdf
 
U.S. Bancorp (NYSE:USB):
Read Full Report: http://www.insiderslab.com/PR3/011713A/USB/USBancorp.pdf
 
KeyCorp (NYSE:KEY):
Read Full Report: http://www.insiderslab.com/PR3/011713A/KEY/KeyCorp.pdf
 
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
 
About Insiderslab.com:
 
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
 
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
 
CONTACT: Insiders.hk, Insiderslab.com, info@insiderslab.com, Support@insiders.hk
SOURCE Insiderslab.com; Insiders.hk
Editor: Janet Nan Jiang
 
 
Source:
insiderslab.com
www.insiderslab.com

Reported on Jan 17, 2013

 
More Insider News ...

Today's Notable Trades


CBS CORP (CBS, CBS.A)
First-Class Insider (Executive Chairman): REDSTONE SUMNER M

Acquired 47,800 CBS Class B common stock (Non-Derivative security at $30.210) on Sep 17, 2014. Direct holding 250,293 shares/units after transaction. Holdings increased 23.61%.
Filing date: Sep 18, 2014. Record updated at 22:18:27.
 
VEEVA SYSTEMS INC (VEEV)
Senior Officer (Chief Financial Officer): Cabral Timothy S

Sold 30,000 Class A Common Stock (Non-Derivative security at $29.436) on Sep 17, 2014. Direct holding 0 shares/units after transaction. Holdings decreased -100.00%.
Filing date: Sep 18, 2014. Record updated at 22:17:33.
 
BROCADE COMMUNICATIONS SYSTEMS INC (BRCD)
Senior Officer (CTO & VP Corporate Development): CHENG KEN

Sold 29,000 Common Stock (Non-Derivative security at $10.503) on Sep 18, 2014. Indirect holding 225,727 shares/units after transaction. Holdings decreased -11.38%.
Filing date: Sep 18, 2014. Record updated at 22:15:46.
 
WESTERN DIGITAL CORP (WDC)
Senior Officer (Sr. VP, Gen Cnsl & Secretary): RAY MICHAEL CHARLES

Sold 12,384 Common Stock (Non-Derivative security at $97.882) on Sep 18, 2014. Direct holding 20,567 shares/units after transaction. Holdings decreased -37.58%.
Filing date: Sep 18, 2014. Record updated at 22:07:14.
 
MEDIVATION, INC. (MDVN)
Senior Officer (Chief Medical Officer): Seely Lynn

Acquired 10,000 Common Stock (Non-Derivative security at $10.585) on Sep 17, 2014. Direct holding 69,022 shares/units after transaction. Holdings increased 16.94%.
Filing date: Sep 18, 2014. Record updated at 22:04:05.
 
UNITED THERAPEUTICS Corp (UTHR)
First-Class Insider (President & COO): JEFFS ROGER

Acquired 20,000 Common Stock (Non-Derivative security at $33.140) on Sep 17, 2014. Direct holding 21,234 shares/units after transaction. Holdings increased 1,620.75%.
Filing date: Sep 18, 2014. Record updated at 22:03:47.
 
Receptos, Inc. (RCPT)
Other: HINKLE DAVID A

Sold 1,375 Common Stock (Non-Derivative security at $64.820) on Sep 17, 2014. Direct holding 0 shares/units after transaction. Holdings decreased -100.00%.
Filing date: Sep 18, 2014. Record updated at 22:03:11.
 
IDT CORP (IDT)
Senior Officer (Chief Executive Officer): JONAS SAMUEL

Acquired 12,414 Class B Common Stock, par value $.01 per share (Non-Derivative security at $16.110) on Sep 17, 2014. Direct holding 107,375 shares/units after transaction. Holdings increased 13.07%.
Filing date: Sep 18, 2014. Record updated at 18:58:15.
 
Stellus Capital Investment Corp (SCM)
Director: Davis Joshua T.

Acquired 12,072 Common Stock (Non-Derivative security at $13.919) on Sep 16, 2014. Direct holding 88,759 shares/units after transaction. Holdings increased 15.74%.
Filing date: Sep 18, 2014. Record updated at 18:57:57.
 
ODYSSEY MARINE EXPLORATION INC (OMEX)
Senior Officer (CFO): Devine Philip S

Sold 6,837 Common Stock (Non-Derivative security at $1.000) on Sep 16, 2014. Direct holding 18,163 shares/units after transaction. Holdings decreased -27.35%.
Filing date: Sep 18, 2014. Record updated at 18:55:34.
 
Read more

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.